Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Melanocyte-stimulating hormone receptor | ||
Ligand | BDBM50310323 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_608232 (CHEMBL1072421) | ||
EC50 | 11800±n/a nM | ||
Citation | Ovadia, O; Linde, Y; Haskell-Luevano, C; Dirain, ML; Sheynis, T; Jelinek, R; Gilon, C; Hoffman, A The effect of backbone cyclization on PK/PD properties of bioactive peptide-peptoid hybrids: the melanocortin agonist paradigm. Bioorg Med Chem18:580-9 (2010) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Melanocyte-stimulating hormone receptor | |||
Name: | Melanocyte-stimulating hormone receptor | ||
Synonyms: | MC1-R | MSHR_MOUSE | Mc1r | Melanocortin receptor 1 | Melanocyte-stimulating hormone receptor | Msh-r | ||
Type: | PROTEIN | ||
Mol. Mass.: | 35238.60 | ||
Organism: | Mus musculus | ||
Description: | ChEMBL_1498846 | ||
Residue: | 315 | ||
Sequence: |
| ||
BDBM50310323 | |||
n/a | |||
Name | BDBM50310323 | ||
Synonyms: | (S)-2-((R)-2-(2-(2-acetamido-N-benzylacetamido)acetamido)-3-phenylpropanamido)-N-((S)-1-(2-amino-2-oxoethylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-5-guanidinopentanamide | CHEMBL602650 | ||
Type | Small organic molecule | ||
Emp. Form. | C41H51N11O7 | ||
Mol. Mass. | 809.9131 | ||
SMILES | CC(=O)NCC(=O)N(CC(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(N)=O)Cc1ccccc1 |r,wU:23.23,12.11,wD:34.34,(-10.03,-9.43,;-8.69,-10.2,;-8.69,-11.74,;-7.36,-9.43,;-6.02,-10.2,;-4.69,-9.43,;-4.69,-7.89,;-3.35,-10.2,;-2.02,-9.43,;-.69,-10.2,;-.69,-11.74,;.64,-9.43,;1.98,-10.2,;1.98,-11.74,;3.31,-12.51,;3.31,-14.06,;4.64,-14.82,;5.98,-14.06,;5.97,-12.51,;4.64,-11.74,;3.31,-9.43,;3.31,-7.89,;4.65,-10.2,;5.98,-9.43,;5.98,-7.89,;7.31,-7.1,;7.29,-5.56,;5.95,-4.81,;5.93,-3.29,;4.58,-2.53,;7.25,-2.5,;7.32,-10.2,;7.32,-11.74,;8.65,-9.43,;9.98,-10.2,;9.98,-11.74,;11.32,-12.51,;12.55,-11.58,;13.82,-12.46,;13.38,-13.93,;14.16,-15.24,;13.43,-16.59,;11.89,-16.62,;11.09,-15.3,;11.84,-13.96,;11.32,-9.43,;11.32,-7.89,;12.65,-10.2,;13.99,-9.43,;15.32,-10.2,;16.65,-9.43,;15.32,-11.74,;-3.35,-11.74,;-4.69,-12.51,;-6.02,-11.73,;-7.35,-12.5,;-7.35,-14.05,;-6.01,-14.81,;-4.68,-14.04,)| | ||
Structure |